Stockscreener 앱 받기
8.40
0.12%
0.010
전일 마감가:
$8.39
열려 있는:
$8.4
하루 거래량:
1.40M
Relative Volume:
0.99
시가총액:
$1.31B
수익:
$53.61M
순이익/손실:
$-142.52M
주가수익비율:
-7.5676
EPS:
-1.11
순현금흐름:
$-141.83M
1주 성능:
+0.72%
1개월 성능:
+22.63%
6개월 성능:
-30.06%
1년 성능:
+33.33%
1일 변동 폭
$8.11
$8.46
1주일 범위
$7.69
$8.72
52주 변동 폭
$5.04
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
명칭
Wave Life Sciences Ltd
전화
617-949-2900
주소
7 STRAITS VIEW, SINGAPORE
WVE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
8.40 | 1.31B | 53.61M | -142.52M | -141.83M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 개시 | Citigroup | Buy |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Wedbush | Outperform |
| 2025-02-25 | 개시 | Jefferies | Buy |
| 2024-10-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | 재개 | JP Morgan | Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-09-09 | 개시 | JP Morgan | Overweight |
| 2024-05-15 | 개시 | Wells Fargo | Overweight |
| 2023-12-19 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 개시 | Raymond James | Outperform |
| 2023-05-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-15 | 재개 | H.C. Wainwright | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | 개시 | Guggenheim | Buy |
| 2019-07-15 | 개시 | Cowen | Market Perform |
| 2019-04-17 | 재확인 | H.C. Wainwright | Buy |
| 2018-08-07 | 개시 | Stifel | Buy |
| 2018-07-23 | 개시 | H.C. Wainwright | Buy |
| 2018-03-19 | 재확인 | Mizuho | Buy |
| 2017-02-15 | 개시 | H.C. Wainwright | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-12-07 | 개시 | JMP Securities | Mkt Outperform |
| 2015-12-07 | 개시 | Jefferies | Buy |
| 2015-12-07 | 개시 | Leerink Partners | Outperform |
| 2015-12-07 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Wave Life Sciences Ltd 주식(WVE)의 최신 뉴스
Wave Life Sciences Ltd. Stock Analysis and ForecastSuperior risk-adjusted returns - PrintWeekIndia
What risks could impact Wave Life Sciences Ltd. stock performanceConsistently exceptional gains - jammulinksnews.com
Is Wave Life Sciences Ltd. a good long term investmentLightning-fast growth - Autocar Professional
Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 - GlobeNewswire
Wave Life Sciences to Host Webcast for Q2 2025 Financial Results and Business Updates - Quiver Quantitative
What drives Wave Life Sciences Ltd. stock priceFree Stock Selection - jammulinksnews.com
Why Wave Life Sciences Ltd. stock attracts strong analyst attentionFree Join Group - Newser
What analysts say about Wave Life Sciences Ltd. stockRemarkably fast returns - jammulinksnews.com
(WVE) Investment Analysis - news.stocktradersdaily.com
Wave Life Sciences Ltd.'s (NASDAQ:WVE) 27% Price Boost Is Out Of Tune With Revenues - 富途牛牛
WAVE Life Sciences (NASDAQ:WVE) Research Coverage Started at Citigroup - Defense World
Will WAVE's Q1 2025 forecast meet expectations? - AInvest
When is the best time to buy Wave Life Sciences Ltd. stockReturn Maximized Portfolio Strategy - Newser
WAVE Life Sciences Receives Buy Rating and USD 16 Price Target from Citigroup - AInvest
Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions - MSN
Wave Life Sciences’ SWOT analysis: RNA editing stock poised for breakthrough - Investing.com Australia
Jessica Chen - White & Case LLP
Breaking Down WAVE Life Sciences: 4 Analysts Share Their Views - Benzinga
Citi initiates coverage on WAVE Life Sciences stock with Buy rating - Investing.com Australia
Citi initiates coverage on WAVE Life Sciences stock with Buy rating By Investing.com - Investing.com South Africa
What makes Wave Life Sciences Ltd. stock price move sharplyFree Stock Index Interpretation - Newser
13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey
Leerink Partners Reiterates a Buy Rating on Wave Life Sciences (WVE), Keeps the PT at $24 - Yahoo Finance
Wave Life Sciences stock reiterated Overweight by Cantor Fitzgerald - Investing.com South Africa
How the (WVE) price action is used to our Advantage - news.stocktradersdaily.com
Huntington's Disease Pipeline 2025: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight Spark Therapeutics, Chong Kun Dang Pharma, Neuvivo, Uniqure Biopharma, Wave Life Sciences, Novartis - MenaFN
Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months (NASDAQ:WVE) - Seeking Alpha
We Think Wave Life Sciences (NASDAQ:WVE) Needs To Drive Business Growth Carefully - simplywall.st
Wave Life Sciences: Speculative, But Promising (NASDAQ:WVE) - Seeking Alpha
H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release - Insider Monkey
Wave Life Sciences Ltd (WVE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
0.22%
자본화:
|
볼륨(24시간):